Ratings by National Securities
| Date | Analyst | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|---|
| 2/9/2021 | N/A | Oramed Pharma | ORMP | New Coverage | Buy (N/A) |
23.00 (N/A) |
10.03 (4.03) |
-59.82% | Details |
| 1/26/2021 | N/A | Genprex | GNPX | New Coverage | Buy (N/A) |
7.00 (N/A) |
4.24 (7.67) |
80.9% | Details |
 |
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
| 192 more... | |||||||||
